Attenuation of oxygen-induced abnormal lung maturation in rats by retinoic acid: Possible role of cytochrome P4501A enzymes

Journal of Pharmacology and Experimental Therapeutics

Volumn 317, Issue 3, 2006, Pages 946-954

  Couroucli, Xanthi I ^a   Liang, Yanhong W ^a   Jiang, Weiwu ^a   Barrios, Roberto ^b   Moorthy, Bhagavatula ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A; DRUG VEHICLE; MESSENGER RNA; OXYGEN; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BODY WEIGHT; BREATHING; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; FETUS LUNG MATURATION; GENE EXPRESSION; HYPEROXIA; LUNG INJURY; LUNG VENTILATION; LUNG WEIGHT; MICROPHOTOGRAPHY; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; ENZYME INHIBITORS; HYPEROXIA; LUNG; MALE; ORGAN SIZE; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRETINOIN;

EID: 33646790532     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.100677     Document Type: Article

References (40)

1. Bourbon J, Boucherat O, Chailley-Heu B, and Delacourt C (2005) Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 57:38R-46R.
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye-binding protein. Anal Biochem 72:248-254.
3. Bucher JR and Roberts RJ (1981) The development of the newborn rat lung in hyperoxia: a dose-response study of lung growth, maturation and changes in antioxidant enzyme activities. Pediatr Res 15:999-1008.
4. Chambon P (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10:940-954.
5. Clerch LB, Baras AS, Massaro GD, Hoffman EP, and Massaro D (2004) DNA microarray analysis of neonatal mouse lung connects regulation of KDR with dexamethasone-induced inhibition of alveolar formation. Am J Physiol 286:L411-L419.
6. Couroucli XI, Wei Y-H, Jiang W, Muthiah K, Evey LW, Barrios R, and Moorthy B (2006) Modulation of pulmonary cytochrome P4501A1 expression by hyperoxia and inhaled nitric oxide in the newborn rat: implications for lung injury. Pediatr Res 59:401-406.
7. Couroucli XI, Welty SE, Geske RS, and Moorthy B (2002) Regulation of pulmonary and hepatic cytochrome P4501A expression in the rat by hyperoxia: implications for hyperoxic lung injury. Mol Pharmacol 61:507-515.
8. Fallone F, Villard PH, Seree E, Rimet O, Nguyen QB, Bourgarel-Rey V, Fouchier F, Barra Y, Durand A, and Lacarelle B (2004) Retinoids repress Ah receptor CYP1A1 induction pathway through the SMRT corepressor. Biochem Biophys Res Commun 332:551-556.
9. Frank L (1991) Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med 11:463-494.
10. Fujita I, Sindhu RK, and Kikkawa Y (1995) Hepatic cytochrome P450 enzyme imprinting in adult rat by neonatal benzo[a]pyrene administration. Pediatr Res 37:646-651.
11. Gambone CJ, Hutcheson JM, Gabriel JL, Beard RL, Chandraratna RA, Soprano KJ, and Soprano DR (2002) Unique property of some synthetic retinoids: activation of the aryl hydrocarbon receptor pathway. Mol Pharmacol 61:334-342.
12. Gonder JC, Proctor RA, and Will JA (1985) Genetic differences in oxygen toxicity are correlated with cytochrome P450 inducibility. Proc Natl Acad Sci USA 82:6315-6319.
13. Gudas L, Sporn MB, and Roberts AB (1994) Cellular biology and biochemistry of retinoids, in The Retinoids (Sporn MB, Roberts AB, and Goodman DS eds) pp 443-520, Raven Press, New York, NY.
14. Guengerich FP (1990) Enzymatic oxidation of xenobiotic chemicals. CRC Crit Rev Biochem Mol Biol 25:97-153.
15. Jiang W, Welty SE, Couroucli XI, Barrios R, Kondraganti SR, Muthiah K, Yu L, Avery SE, and Moorthy B (2004) Disruption of the Ah receptor gene alters the susceptibility of mice to oxygen-mediated regulation of pulmonary and hepatic cytochromes P4501A expression and exacerbates hyperoxic lung injury. J Pharmacol Exp Ther 310:512-519.
16. Lin Y-J, Markham NE, Balasubramaniam V, Tang J-R, Maxey A, Kinsella JP, and Abman SH (2005) Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 58:222-229.
17. Mansour H, Brun-Pascaud M, Marquetty C, Gougerot-Pocidalo M, Hakim J, and Pocidalo JJ (1988a) Protection of rat from oxygen toxicity by inducers of cytochrome P450 system. Am Rev Respir Dis 137:688-694.
18. Mansour H, Levacher M, Azoulay-Dupuis E, Moreau J, Marquetty C, and Gougerot-Pocidalo MA (1988b) Genetic differences in response to pulmonary cytochrome P-450 inducers and oxygen toxicity. J Appl Physiol 64:1376-1381.
19. Margraf LR, Tomashefski JF Jr, Bruce MC, and Dahms BB (1991) Morphometric analysis of the lung in prolonged bronchopulmonary dysplasia. Am Rev Respir Dis 143:391-400.
20. Massaro GD and Massaro D (2000) Retinoic acid partially rescues failed septation in rats and mice. Am J Physiol 278:L955-L960.
21. Moorthy B (2000) Persistent expression of 3-methylcholanthrene-inducible cytochrome P4501A in rat hepatic and extrahepatic tissues. J Pharmacol Exp Ther 294:313-322.
22. Moorthy B, Nguyen UTL, Gupta S, Stewart KD, Welty SE, and Smith CV (1997) Induction and decline of hepatic cytochromes P4501A1 and 1A2 in rats exposed to hyperoxia are not paralleled by changes in glutathione S-transferase-α. Toxicol Lett 90:67-75.
23. Moorthy B, Parker KM, Smith CV, Bend JR, and Welty SE (2000) Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P450 inhibitor, 1-aminobenzotriazole. J Pharmacol Exp Ther 292:553-560.
24. Moorthy B, Wang L, Muthiah K, Couroucli X, Barrios R, Kondraganti SR, and Jiang W (2005) Differential modulation of hyperoxic lung injury in mice deficient in the genes for CYP1A2 or CYP2E1, in 14th International Conference on Cytochromes P450. Biochemistry, Biophysics and Bioinformatics; 2005 May 31-Jun 5; Bologna, Italy. pp 193-198, Medimond International Proceedings, Bologna, Italy.
25. Northway WH and Rosan RC (1968) Radiographic features of pulmonary oxygen toxicity in the newborn: Bronchopulmonary dysplasia. Radiology 91:49-57.
26. Okamoto T, Mitsuhashi M, Fujita I, Sindhu RK, and Kikkawa Y (1993) Induction of cytochrome P4501A1 and 1A2 by hyperoxia. Biochem Biophys Res Commun 197: 878-885.
27. Okey AB, Riddick DS, and Harper PA (1994) The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol Lett 70:1-22.
28. Omeicinski CJ, Hassett C, and Costa P (1990) Developmental expression and in situ localization of the phenobarbital-inducible rat hepatic mRNAs for cytochromes CYP2B1, CYP2B2, CYP2C6 and CYP3A1. Mol Pharmacol 38:462-470.
29. Ozer EA, Kumral A, Ozer E, Duman N, Yilmaz O, Ozkal S, and Ozkan H (2005) Effect of retinoic acid on oxygen-induced lung injury in the newborn rat. Pediatr Pulmonol 39:35-40.
30. Pohl RJ and Fouts JR (1980) A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal Biochem 107:150-155.
31. Rushing SR and Denison MS (2002) The silencing mediator of retinoic acid and thyroid hormone receptors can interact with the aryl hydrocarbon (Ah) receptor but fails to repress Ah receptor-dependent gene expression. Arch Biochem Biophys 403:189-201.
32. Sinha A, Muthiah K, Jiang W, Couroucli X, Barrios R, and Moorthy B (2005) Attenuation of hyperoxic lung injury by the cytochrome P4501A1 inducer, β-naphthoflavone. Toxicol Sci 87:204-212.
33. Soprano DR, Gambone CJ, Sheikh SN, Gabriel JL, Chandraratna RA, Soprano KJ, and Kochhar DM (2001) The synthetic retinoid AGN 193109 but not retinoic acid elevates CYP1A1 levels in mouse embryos and hepa-1c1c7 cells. Toxicol Appl Pharmacol 174:153-159.
34. Thibeault DW, Downing G, Reddy N, Sonderfan AJ, and Parkinson A (1991) Oxygen-induced lung damage in newborn rats, potentiated by 3-methylcholanthrene, a P-450 inducer and lack of protection by cimetidine, a P450 inhibitor. J Pharmacol Exp Ther 259:444-451.
35. Thomas PE, Reik LM, Ryan DE, and Levin W (1984) Characterization of nine monoclonal antibodies against rat hepatic cytochrome P450c. Delineation of at least five spatially distinct epitopes. J Biol Chem 259:3890-3899.
36. Tsai SH, Anderson WR, Strickland MB, and Pliego M (1972) Bronchopulmonary dysplasia associated with oxygen therapy in infants with respiratory distress syndrome. Radiology 105:107-115.
37. Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, Stoll BJ, Lemons JA, Stevenson DK, Bauer CR, et al. (1999) Vitamin A supplementation for extremely-low-birth-weight infants. National Institutes of Child Health and Human Developmental Neonatal Research Network. N Engl J Med 340:1962-1968.
38. Veness-Meehan KA, Pierce RA, Moats-Staats BM, and Stiles AD (2002) Retinoic acid attenuates O2-induced inhibition of lung septation. Am J Physiol 283:L971-L980.
39. Wang H and Strobel HW (1998) Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Arch Biochem Biophys 344:365-372.
40. Yang YM, Huang DY, Liu GF, Zhong JC, Du K, Li YF, and Song XH (2005) Inhibitory effects of vitamin A on TCDD-induced cytochrome P4501A1 enzyme activity and expression. Toxicol Sci 85:727-734.